DHAI (DIH Holding US) Total Receivables: $7.39 Mil (As of Mar. 2025)


What is DIH Holding US Total Receivables?

DIH Holding US DHAI +4,900.00% Total Receivables is $7.39 Mil as of Mar. 2025.

DIH Holding US's Total Receivables for the quarter that ended in Mar. 2025 was $7.39 Mil.

DIH Holding US Total Receivables Related Terms

DIH Holding US Total Receivables Historical Data

* Premium members only.

The historical data trend for DIH Holding US's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DIH Holding US Total Receivables Chart

DIH Holding US Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Total Receivables
15.93 15.44 11.52 7.39

DIH Holding US Quarterly Data
Mar22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.52 12.01 13.39 10.89 7.39

DIH Holding US Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $7.39 Mil mean?
DIH Holding US (DHAI) has a Total Receivables of $7.39 Mil as of Mar. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on DIH Holding US and its competitors.
Is DIH Holding US's Total Receivables too high?
DIH Holding US's current Total Receivables is $7.39 Mil.
How does DIH Holding US's Total Receivables compare to ABT and SYK?
DIH Holding US's Total Receivables of $7.39 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Devices & Instruments company?
A good Total Receivables depends on the Medical Devices & Instruments industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on DIH Holding US and its competitors. DIH Holding US's current Total Receivables is $7.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DIH Holding US stock overvalued right now?
DIH Holding US (DHAI) has a current Total Receivables of $7.39 Mil. The current Total Receivables is $7.39 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For DIH Holding US (DHAI), the current Total Receivables is $7.39 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DIH Holding US Business Description

Address 77 Accord Park Drive, Suite D-1, Norwell, MA, USA, 02061
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. It serves the healthcare systems, clinics, third-party healthcare providers, distributors and other institutions by providing a broad array of devices and services focused on the customer and patient recovery. Its key products are LokoMat, Erigo, Armeo, C-Mill and CAREN/Grail. Geographically, the company derives revenue from the EMEA, Americas, and Asia Pacific regions. The company generates revenue from the sale of medical rehabilitation devices and technology.